Use of a reliable contraception method has become an inclusion criterion in prevention trials to minimize time off product. We report on hormonal contraceptive prevalence, uptake, sustained use and correlates of use in the Microbicides Development Programme (MDP 301) trial at the Masaka Centre in Uganda.
HIV negative women in sero-discordant relationships were enrolled and followed-up for 52 to 104 weeks from 2005 to 2009. Contraceptive use data was collected through self-report at baseline and dispensing records during follow-up. Hormonal contraceptives were promoted and provided to women that were not using a reliable method at enrolment. Baseline contraceptive prevalence, uptake and sustained use were calculated. Uptake was defined as a participant who reported not using a reliable method at enrolment and started using a hormonal method at any time after. Logistic regression models were fitted to investigate predictors of hormonal contraceptive uptake.
A total of 840 women were enrolled of whom 21 aged ≥50 years and 12 without follow-up data were excluded; leaving 807 (median age 31 IQR 26–38) in this analysis. At baseline, 228 (28%) reported using a reliable contraceptive; 197 hormonal, 28 female-sterilisation, two IUCD and one hysterectomy. As such 579 were not using a reliable contraceptive at enrolment, of whom 296 (51%) subsequently started using a hormonal contraceptive method; 253 DMPA, four oral pills, and two norplant. Overall 193 (98%) existing users and 262 (88%) new users sustained use throughout follow-up. Independent correlates of hormonal contraceptive uptake were: younger women ≤30 years, aOR = 2.5, 95% CI: 1.7–3.6 and reporting not using contraceptives at baseline due to lack of access or money, breastfeeding or other reasons, in comparison to women who reported using unreliable method.
Promotion and provision of hormonal contraception doubled the proportion of women using a reliable method of contraception. Uptake was pronounced among younger women and those not previously using a reliable method because of lack of access or money, and breastfeeding. Promotion and provision of hormonal contraceptives in trials that require the interruption or discontinuation of investigational products during pregnancy is important to reduce the time off product.
Protocol Number ISRCTN64716212.
WHO. http://who.int/mediacentre/factsheets/fs351/en/. Accessed 27 Feb 2017.
Singh S, Darroch JE. Adding It Up: costs and benefits of contraceptive services estimates for 2012. New York: Guttmacher Institute and United Nations Population Fund (UNFPA); 2012. https://www.guttmacher.org/report/adding-it-costs-and-benefits-contraceptive-services-estimates-2012. Accessed 27 Feb 2017.
Uganda Bureau of Statistics. Uganda Demographic and Health Survey 2011
Jimmy R, Robert W, Bruno O, Allen K. Modern contraceptive use among women in Uganda. An analysis of trend and petterns (1995–2011). Etude Popul Afr. 2014;28(2):1009–21. doi: 10.11564/28-0-553.
Population reference Bureau. World population data sheet 2011.
Guttmacher Institute. Contraception and Unintended Pregnancy in Uganda. Fact sheet 2013. http://www.guttmacher.org/pubs/FB-Contraception-and-unintended-pregnancy-in-Uganda.html. Accessed 20 Nov 2015.
Khan Shane, Sarah E.K. Bradley, Joy Fishel, Vinod Mishra. Unmet Need and the Demand for Family Planning in Uganda: Further Analysis of the Uganda Demographic and Health Surveys, 1995–2006. Calverton, Maryland, USA: Macro International Inc.
Corinne Dietiker, Cristin Gordon-Maclean, Lois K. Nantayi, Heidi Quinn, Thoai D. Ngo. Task sharing: Safety and acceptability of tubal ligation provision by trained clinical officers in rural Uganda. Research brief series (007) 2013.
Uganda Ministry of Health (MOH). Press release of key results of the 2011 Uganda AIDS indicator survey
Uganda AIDS Commission. National strategic plan for HIV&AIDS 2011/12 -2014/15
Heena B, Makumbi F, Lutalo T, Sekasanvu J, Serwadda D, Wawer MJ, et al. Longitudinal study of correlates of modern contraceptive use and impact of HIV care programmes among HIV concordant and serodiscordant couples in Rakai, Uganda. J Fam Plann Reprod Health Care. 2014;40:208–16. CrossRef
Heffron R, Were E, Celum C, Mugo N, Ngure K, Kiarie J, et al. A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships. Sex Transm Dis. 2010;37(10):621–8. PubMed
Nayiga I, Semitala F.C, Matsiko N, Mutumba R, Nawavvu C, Namusobya J, et al. Low uptake of dual contraception methods and high prevalence of unwanted pregnancies among HIV-infected women in Uganda. In Proceedings of International AIDS society (IAS) Conference: Kuala Lumpur, Malaysia: 2013.
Mumtaz Z, Slaymaker E, and Salway S. Condom use in Uganda and Zimbabwe: exploring the influence of gendered access to resources and couple-level dynamics. https://pdfs.semanticscholar.org/dfa6/3425bf94f45a8da96e73f06359e250e28efe.pdf. Accessed 27 Feb 2017.
Kibengo FM, Ruzagira E, Katende D, Bwanika AN, Bahemuka U, Jessica EH, et al. Safety, Adherence and Acceptability of Intermittent Tenofovir/ Emtricitabine as HIV Pre-Exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial. PLoS One. 2013;8(9):e74314. doi: 10.1371/journal.pone.0074314. CrossRefPubMedPubMedCentral
Marrazzo J, Ramjee G, Nair G et al. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE study (MTN 003). 20th Conference on Retroviruses and Opportunistic Infections. Atlanta. March 3–6, 2013. Abstract #26LB.
Nunn A, McCormack S, Crook AM, Pool R, Rutterford C, Hayes R. Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009;10(1):99.
Jentsch U, Lunga P, Lacey C, Weber J, Cairns J, Gisela P, et al. The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301). PLoS One. 2012;7(9):e42322. doi: 10.1371/journal.pone.0042322. CrossRefPubMedPubMedCentral
Asiimwe JB, Ndugga P, Mushomi J, Ntozi MJP. Factors associated with modern contraceptive use among young and older women in Uganda; a comparative analysis. BMC Public Health. 2014. doi: 10.1186/1471-2458-14-926.
Jaoko W G, Ogutu H, Wakasiaka S, Malogo R, Ndambuki R, Nyange J, et al. Pregnancy rates among female participants in phase I and Phase IIA AIDS Vaccine Clinical Trials in Kenya. East Afr Med J. 2009:86(9).
Okech CT, Wawire WN, Mburu KT. Contraceptive Use among Women of Reproductive Age in Kenya’s City Slums. Int J Bus Soc Sci. 2011:2(1).
The tragic impact of unsafe abortion and inadequate access to contraception in Uganda. Center for Reproductive Rights, the International Women’s Human Rights Clinic (IWHRC), Georgetown Law Center Washington. The stakes are high report 2013. http://tbinternet.ohchr.org/Treaties/CESCR/Shared%20Documents/UGA/INT_CESCR_CSS_UGA_20279_E.pdf. Accessed 27 Feb 2017.
Agbo HA, Ogbonna C, Okeahialam BN. Factors related to the uptake of contraceptive in a rural community in Plateau State Nigeria: a cross-sectional community study. J Med Trop. 2013;15:107–12. CrossRef
Ashford L. Unmet need for family planning: Recent Trends and Their Implications for Programs. Population reference bureau Measure Communication. Policy brief 2003.
Kawuma R: Role of men in a phase III vaginal microbicide trial in SW Uganda. In Proceedings of Microbicides Conference: 24–27. New Delhi, India: 2008.
WHO. Medical eligibility criteria for contraceptive use. 4th ed. Geneva: WHO; 2010.
WHO, Hormonal contraception and HIV . Technical statement 2012.
Babirye S K. Uptake of modern contraception among youths (15–24) at community level in Busia district, Uganda. 2013 accessed at https://scholar.google.com/scholar?hl=en&q=Babirye+S+K.+Uptake+of+modern+contraception+among+youths+%2815%E2%80%9324%29+at+community+level+in+Busia+dist. Accessed 27 Feb 2017.
- Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda
- BioMed Central
Neu im Fachgebiet Gynäkologie und Geburtshilfe
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II